Education
About Us
Working with TipRanks
Follow Us
IR BioSciences Holdings Inc (IRBS)
OTHER OTC:IRBS
IRBS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume1.00K
Average Volume (3M)0.00
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-31.49
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding17,083,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
0.42% Other Institutional Investors
99.58% Public Companies and
Individual Investors
IRBS FAQ
What was IR BioSciences Holdings Inc’s price range in the past 12 months?
IR BioSciences Holdings Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is IR BioSciences Holdings Inc’s market cap?
Currently, no data Available
When is IR BioSciences Holdings Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were IR BioSciences Holdings Inc’s earnings last quarter?
Currently, no data Available
Is IR BioSciences Holdings Inc overvalued?
According to Wall Street analysts IR BioSciences Holdings Inc’s price is currently Overvalued.
Does IR BioSciences Holdings Inc pay dividends?
IR BioSciences Holdings Inc does not currently pay dividends.
What is IR BioSciences Holdings Inc’s EPS estimate?
IR BioSciences Holdings Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IR BioSciences Holdings Inc have?
IR BioSciences Holdings Inc has 17,083,000 shares outstanding.
What happened to IR BioSciences Holdings Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of IR BioSciences Holdings Inc?
Currently, no hedge funds are holding shares in IRBS
Company Description
IR BioSciences Holdings Inc
IR BioSciences Holdings, Inc. operates as a development stage biotechnology company in the United States. The company, through its subsidiary, ImmuneRegen BioSciences, Inc., engages in the research and development of therapies in the areas of pulmonary fibrosis, influenza infection, and radiation-induced Neutropenia. It is involved in the development of Homspera, and its derivates Radilex and Viprovex, for human stem cell stimulation, immune system stimulation and anti-infective activity, vaccine adjuvancy, and wound healing. IR BioSciences Holdings, Inc. was founded in 1999 and is headquartered in Scottsdale, Arizona.
Technical Analysis
Biodexa Pharmaceuticals
―
Salarius Pharmaceuticals
―
Processa Pharmaceuticals
―
GRI Bio
―
Onconetix
―